Expression and action of the growth hormone releasing peptide ghrelin and its receptor in prostate cancer cell lines
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
This study has examined the expression of two new facets of the growth hormone axis, the growth hormone secretagogue receptor (GHS-R) and its recently identified putative natural ligand ghrelin, in prostate cancer cells. GHS-R 1a and 1b isoforms and ghrelin mRNA expression were detected by RT-PCR in the ALVA-41, LNCaP, DU145 and PC3 prostate cancer cell lines. A normal prostate cDNA library expressed GHS-R1a, but not the 1b isoform or ghrelin. Immunohistochemical staining for the GHS-R 1a isoform and ghrelin was positive in the four cell lines studied. PC3 cells showed increased cell proliferation in vitro in response to ghrelin to levels 33% above untreated controls, implying a potential tumour-promoting role for ghrelin in this tissue. This study is the first to demonstrate the co-expression of the GHS-R and ghrelin in prostate cancer cells. It is also the first study to provide evidence that a previously unrecognised autocrine/paracrine pathway involving ghrelin, that is capable of stimulating growth, exists in prostate cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ghrelin is a growth-hormone-releasing acylated peptide from stomach
Kojima, M., Hosoda, H., Date, Y., Nakazato, M., Matsuo, H., & Kangawa, K. (1999) · Nature · doi:10.1038/45230 · Cited by 8,479 · cited 5×
“Ghrelin mRNA expression has been demonstrated in rodent brain and some rodent peripheral tissues and in human stomach (Kojima et al. 1999).”
BackgroundInfluential
Cited by
Biological, Physiological, Pathophysiological, and Pharmacological Aspects of Ghrelin
van der Lely, A. J., Tschöp, M., Heiman, M. L., & Ghigo, E. (2004) · Endocrine Reviews · doi:10.1210/er.2002-0029 · Cited by 1,187
“The PC-3 prostate cancer cell line, however, showed increased cell proliferation in vitro after exposure to ghrelin, suggesting that autocrine-paracrine pathways involving ghrelin might be capable of stimulating cell proliferation (46).”
BackgroundGhrelin?a hormone with multiple functions
KORBONITS, M. (2004) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2004.03.002 · Cited by 595
Neary, N. M., Small, C. J., Wren, A. M., Lee, J. L., Druce, M. R., Palmieri, C., Frost, G. S., Ghatei, M. A., Coombes, R. C., & Bloom, S. R. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031768 · Cited by 456
Ghrelin, appetite, and gastric motility: the emerging role of the stomach as an endocrine organ
Inui, A., Asakawa, A., Y. Bowers, C., Mantovani, G., Laylano, A., M. Meguid, M., & Fujimiya, M. (2004) · The FASEB Journal · doi:10.1096/fj.03-0641rev · Cited by 431
Ghrelin in the regulation of body weight and metabolism
Castañeda, T. R., Tong, J., Datta, R., Culler, M., & Tschöp, M. H. (2010) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2009.10.008 · Cited by 352
Seoane, L. M., López, M., Tovar, S., Casanueva, F. F., Señarís, R., & Diéguez, C. (2003) · Endocrinology · doi:10.1210/en.2002-220795 · Cited by 228
Kim, S. W., Her, S. J., Park, S. J., Kim, D., Park, K. S., Lee, H. K., Han, B. H., Kim, M. S., Shin, C. S., & Kim, S. Y. (2005) · Bone · doi:10.1016/j.bone.2005.04.020 · Cited by 207
“Two-fold and 33% increase in cell proliferation was also observed in HepG2 human hepatoma cell line (50 mM of ghrelin) [33] and PC3 prostate cancer cell lines (5 nM of ghrelin) [22], respectively.”
BackgroundGhrelin: more than a natural GH secretagogue and/or an orexigenic factor
Ghigo, E., Broglio, F., Arvat, E., Maccario, M., Papotti, M., & Muccioli, G. (2005) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2004.02160.x · Cited by 202
Gaytan, F., Barreiro, M. L., Caminos, J. E., Chopin, L. K., Herington, A. C., Morales, C., Pinilla, L., Paniagua, R., Nistal, M., Casanueva, F. F., et al. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031375 · Cited by 195
Self-citationObesity and colorectal cancer: Role of adipokines in tumor initiation and progression
Riondino, S. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i18.5177 · Cited by 193
Growth hormone releasing peptide (ghrelin) is synthesized and secreted by cardiomyocytes
IGLESIAS, M. (2004) · Cardiovascular Research · doi:10.1016/j.cardiores.2004.01.024 · Cited by 173
“Ghrelin inhibits the in vitro proliferation of cells of breast carcinoma [33], human lung carcinoma [34], and thyroid carcinoma [35], and promotes that of hepatoma cells [36], prostate cancer cells [27], adrenal cells [37] and, as noted above, H9c2 cardiomyocytes [31].”
BackgroundMethodGhrelin Inhibits the Development of Mouse Preimplantation Embryos in Vitro
Kawamura, K., Sato, N., Fukuda, J., Kodama, H., Kumagai, J., Tanikawa, H., Nakamura, A., Honda, Y., Sato, T., & Tanaka, T. (2003) · Endocrinology · doi:10.1210/en.2003-0033 · Cited by 160
“Ghrelin simulated proliferation of prostate cancer cell line (63) and cardiomyocyte cell line (64).”
Metadata
- Authors
- Jeffery, P., Herington, A., & Chopin, L.
- Venue
- Journal of Endocrinology
- Publisher
- Bioscientifica
- Published
- 2002-03-01
- Volume
- 172
- Issue
- 3
- Pages
- R7-11
- ISSN
- 0022-0795 (ISSN-L)
- 1479-6805
- OpenAlex
- W1487667267
- Cited by
- 201
- References
- 1
- FWCI
- 8.70
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.